Drug Shortage Report for TARO-DEFERASIROX

Last updated on 2018-09-07 History
Report ID 57522
Drug Identification Number 02463547
Brand name TARO-DEFERASIROX
Common or Proper name TARO DEFERASIROX
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) DEFERASIROX
Strength(s) 500MG
Dosage form(s) TABLET FOR SUSPENSION
Route of administration ORAL
Packaging size 30's
ATC code V03AC
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-08-02
Estimated end date 2018-08-17
Actual end date 2018-08-30
Shortage status Resolved
Updated date 2018-09-07
Company comments
Health Canada comments
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-09-07 French Compare
v3 2018-09-07 English Compare
v2 2018-08-03 French Compare
v1 2018-08-03 English Compare